Adelphi Biosciences

Drug and biopharmaceutical developers must steer complex, shifting regulatory requirements from early discovery to market authorization. Adelphi Biosciences provides the regulatory strategy and execution that sponsors need to move programs through that pathway.

Its services span CMC and quality compliance, FDA and global submissions, lifecycle management, and due diligence, complementing in-house teams with submission planning, electronic publishing, and health-authority representation. The firm positions itself as an extension of the client's regulatory function rather than a software vendor.